Richard Wahl

Director, Division of Nuclear Medicine/PET · Stanford Health Care

Credentials: · · · · · · · · ·

History

Precision Next-Generation Radioimmunotherapies to Cure Non-Hodgkin Lymphoma
National Cancer Institute · R01
Contact PI · $1.3M · Washington University
2024–2029
Training OPportunites in Translational Imaging Education and Research (TOP-TIER)
National Institute of Biomedical Imaging and Bioengineering · T32
PI · $2.4M · Washington University
2017–2027
Washington University Co-Clinical Imaging Research Resource
National Cancer Institute · U24
PI · $3.1M · Washington University
2017–2022
Integrative Imaging Informatics for Cancer Research
National Cancer Institute · U24
PI · $3M · Washington University
2016–2022

Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
Principal investigator · Withdrawn · Phase 2
Washington University School of Medicine
2021–2025
Gated and Non-Gated Dynamic PET/CT Imaging
Principal investigator · Terminated
Washington University School of Medicine
2020–2023
18F-FLT PET Imaging in Patients With Advanced Melanoma
Principal investigator · Terminated · Phase 1
Washington University School of Medicine
2016–2017
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Principal investigator · Completed · Phase 1
Washington University School of Medicine
2016–2017

Fellowship from the Society of Nuclear Medicine and Molecular Imaging
2022
Society of Nuclear Medicine and Molecular Imaging